David Bassa
CEO
Claimed by owner Stero Biotechs
Former names:
CBD-based Treatment Solutions
Stero Biotechs
www.prnewswire.com
•
Jan 5, 2021
Stero Biotechs supports an Exploratory Study of CBD-based treatment for COVID-19 severe patients
www.israel-cannabis.com
•
Aug 5, 2020
https://www.israel-cannabis.com/press-release/stero-biotechs-announces-first-patient-in-phase-2a-clinical-trial-for-cbd-effects-on-chronic-spontaneous-urticaria/
www.israel21c.org
•
Jun 18, 2020
CBD may improve steroid therapy in autoimmune, Covid-19 patients
www.algemeiner.com
•
May 3, 2020
Israeli Biotech Company Starts Clinical Trials of CBD-Steroid Treatment for Virus
www.prnewswire.com
•
Apr 20, 2020
Stero Biotechs Announce an IP Protected Clinical Trial for COVID-19 Patients Using a CBD-Steroid Treatment
www.globenewswire.com
•
Apr 13, 2020
Kalytera and Stero Biotechs Will Not Proceed with Acquisition
www.globenewswire.com
•
Mar 18, 2020
Kalytera Provides Additional Detail Regarding Terms of Stero Biotechs, Ltd. Acquisition
www.globenewswire.com
•
Mar 16, 2020
Kalytera Announces Extension of Maturity Date of Promissory Note
www.globenewswire.com
•
Mar 5, 2020
Kalytera to Acquire Stero Biotechs, Ltd.
www.healtheuropa.eu
•
Sep 16, 2019
Are steroids truly a necessary evil? - a groundbreaking CBD-based alternative
ibdnewstoday.com
•
Jul 30, 2019
Clinical Trial in Israel Will Evaluate Cannabidiol-based Product...
www.prnewswire.com
•
Jul 23, 2019
Stero Biotechs to Commence Phase 2a Clinical Trial of Cannabidiol-Based Formulation for Patients With Crohn's Disease
www.healio.com
•
Mar 1, 2019
Stero Biotechs begins trial of CBD to reduce steroid use in autoimmune hepatitis
www.prnewswire.com
•
Aug 29, 2018
STERO Biotechs Secures Patent of CBD as Steroid Sparing Treatment, Breakthrough Will Potentially Allow Significant Dosage Reduction
About
STERO Biotechs is a clinical-stage company that researches and develops novel and improved treatment solutions designed to benefit patients by reducing the side effects of and need for steroid therapy. STERO uses cannabidiol (CBD), a non-psychotropic component of cannabis sativa, which has been shown to possess potent immunomodulatory and anti-inflammatory properties in a variety of indications.
The company has commenced several clinical trials, including phase 2a clinical trials for steroid dependent Crohns disease (IBD) in Q1 2020 and for chronic urticaria (hives) in Q3 2020. In addition, STEROs phase 1/2 clinical trial treating patients with severe COVID-19 started in Q1 2021. Additional clinical trials for more indications are in the pipeline for 2021.
STERO Biotechs was established in partnership with Mor Research Applications, the technology transfer unit of CLALIT Health Services.
The company has commenced several clinical trials, including phase 2a clinical trials for steroid dependent Crohns disease (IBD) in Q1 2020 and for chronic urticaria (hives) in Q3 2020. In addition, STEROs phase 1/2 clinical trial treating patients with severe COVID-19 started in Q1 2021. Additional clinical trials for more indications are in the pipeline for 2021.
STERO Biotechs was established in partnership with Mor Research Applications, the technology transfer unit of CLALIT Health Services.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
ST-101
Geographic markets
-
News
(14)
www.prnewswire.com
•
Jan 5, 2021
Stero Biotechs supports an Exploratory Study of CBD-based treatment for COVID-19 severe patients
www.israel-cannabis.com
•
Aug 5, 2020
https://www.israel-cannabis.com/press-release/stero-biotechs-announces-first-patient-in-phase-2a-clinical-trial-for-cbd-effects-on-chronic-spontaneous-urticaria/
www.israel21c.org
•
Jun 18, 2020
CBD may improve steroid therapy in autoimmune, Covid-19 patients
www.algemeiner.com
•
May 3, 2020
Israeli Biotech Company Starts Clinical Trials of CBD-Steroid Treatment for Virus
www.prnewswire.com
•
Apr 20, 2020
Stero Biotechs Announce an IP Protected Clinical Trial for COVID-19 Patients Using a CBD-Steroid Treatment
www.globenewswire.com
•
Apr 13, 2020
Kalytera and Stero Biotechs Will Not Proceed with Acquisition
www.globenewswire.com
•
Mar 18, 2020
Kalytera Provides Additional Detail Regarding Terms of Stero Biotechs, Ltd. Acquisition
www.globenewswire.com
•
Mar 16, 2020
Kalytera Announces Extension of Maturity Date of Promissory Note
www.globenewswire.com
•
Mar 5, 2020
Kalytera to Acquire Stero Biotechs, Ltd.
www.healtheuropa.eu
•
Sep 16, 2019
Are steroids truly a necessary evil? - a groundbreaking CBD-based alternative
ibdnewstoday.com
•
Jul 30, 2019
Clinical Trial in Israel Will Evaluate Cannabidiol-based Product...
www.prnewswire.com
•
Jul 23, 2019
Stero Biotechs to Commence Phase 2a Clinical Trial of Cannabidiol-Based Formulation for Patients With Crohn's Disease
www.healio.com
•
Mar 1, 2019
Stero Biotechs begins trial of CBD to reduce steroid use in autoimmune hepatitis
www.prnewswire.com
•
Aug 29, 2018
STERO Biotechs Secures Patent of CBD as Steroid Sparing Treatment, Breakthrough Will Potentially Allow Significant Dosage Reduction
The Team
(5)
DB
OA
Ofer Alshech
CFO
Guy Defrin
COO
DSPS
Dr. Sari Prutchi Sagiv
CSO
DMY
Dr. Moshe Yeshurun
CTO
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Undisclosed Round
$1M
Mar 2019
1 Investors
$1M
Others
Affiliation
Mar 2019
Hub Name
BioSeedXL
Batch
1
Media gallery
(0)Locations
Israel
Baruch Hirsch Street 14, Bnei Brak, Israel
Locations
Israel
Baruch Hirsch Street 14, Bnei Brak, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,